Michigan House Bill HB5135

Michigan 2025-2026 Regular Session

• Introduced: 10/23/25
• Refer: 10/23/25

Caption

Marihuana: advertising; use of billboards to advertise medical marihuana; prohibit. Amends secs. 102 & 206 of 2016 PA 281 (MCL 333.27102 & 333.27206) & adds sec. 506.

Impact

This bill will significantly influence the existing state laws governing marihuana marketing strategies. By eliminating billboards as a viable advertising option, it effectively limits how businesses in the marihuana industry can promote their products and services. The anticipated objective is to minimize the visibility of these products, particularly to vulnerable populations, and to maintain a focus on health and safety. The bill is positioned within a broader trend towards stricter oversight of cannabis-related businesses, which has been a subject of ongoing public health and safety discourse following the legalization of marihuana in Michigan.

Summary

House Bill 5135 aims to amend the Medical Marihuana Facilities Licensing Act by adding new regulations surrounding advertising for medical marihuana products. Specifically, the bill prohibits the advertising of marihuana, marihuana-infused products, and marihuana facilities on billboards and digital billboards in the state of Michigan. This legislative measure is being introduced to enhance regulatory control over the marihuana industry and to address concerns regarding the exposure of potent products to minors and the general public. By restricting these advertising mediums, the bill promotes patient safety and responsible consumption practices.

Contention

Noteworthy points of contention surrounding HB 5135 include debates over the implications for free speech and the ability of businesses to market their products. Supporters argue that the restrictions are necessary to protect public health, particularly for minors who could be influenced by aggressive marketing tactics. On the other hand, opponents contend that such measures could impede business growth and infringe on the rights of operators to advertise legally manufactured products. This dialogue reflects the ongoing balancing act policymakers face in the rapidly evolving context of cannabis legalization, where health concerns and economic interests frequently collide.